PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 25, 2024

Primary Completion Date

May 31, 2034

Study Completion Date

May 31, 2034

Conditions
Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 DeficiencyATP-Binding Cassette Subfamily C Member 6 Deficiency
Interventions
OTHER

No Intervention for this observational study

No Intervention for this observational study

Trial Locations (13)

19104

RECRUITING

The Children's Hospital of Philadelphia (CHOP), Philadelphia

20132

RECRUITING

IRCCS San Raffaele Hospital - Main, Milan

20251

RECRUITING

Universitätsklinikum Hamburg-Eppendorf, Hamburg

34764

RECRUITING

Umraniye Training and Research Hospital, Istanbul

55905

RECRUITING

Mayo Clinic, Rochester

60611

RECRUITING

Ann and Robert H. Lurie Children's Hospital, Chicago

02115

RECRUITING

Boston Children's Hospital, Boston

07724

RECRUITING

CLINILABS Drug Development Corp, Eatontown

H3T1C5

RECRUITING

CHU Sainte-Justine Research Centre, Montreal

113-8655

RECRUITING

The University of Tokyo Hospital, Tokyo

Unknown

RECRUITING

Royal Hospital Muscat, Muscat

08950

RECRUITING

Hospital Sant Joan de Deu, Barcelona

DE11 7AQ

RECRUITING

VCTC, Derby

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

GACI Global

UNKNOWN

lead

Inozyme Pharma

INDUSTRY